JP6915774B2 - Testosterone increaser - Google Patents

Testosterone increaser Download PDF

Info

Publication number
JP6915774B2
JP6915774B2 JP2016111367A JP2016111367A JP6915774B2 JP 6915774 B2 JP6915774 B2 JP 6915774B2 JP 2016111367 A JP2016111367 A JP 2016111367A JP 2016111367 A JP2016111367 A JP 2016111367A JP 6915774 B2 JP6915774 B2 JP 6915774B2
Authority
JP
Japan
Prior art keywords
testosterone
tomato
group
water
stress
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016111367A
Other languages
Japanese (ja)
Other versions
JP2017105746A (en
Inventor
久美子 水谷
久美子 水谷
和明 井口
和明 井口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shizuoka University NUC
Original Assignee
Shizuoka University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shizuoka University NUC filed Critical Shizuoka University NUC
Publication of JP2017105746A publication Critical patent/JP2017105746A/en
Application granted granted Critical
Publication of JP6915774B2 publication Critical patent/JP6915774B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Description

本発明は、トマト由来のテストステロン増加剤に関する。 The present invention relates to tomato-derived testosterone-increasing agents.

男性ホルモンの95%を占めるテストステロンは精巣から分泌され、男性の性腺機能はもとより骨や筋肉をつくる強力な働きがあり、女性でも卵巣等でつくられる。また、脳にも影響し、気力や認知機能に関係している。テストステロンは加齢とともに減少することが知られており、性腺機能のみならず記憶、やる気等が減退する男性更年期障害といわれる症状があらわれる。男性更年期障害は緩やかに進行する分、手遅れとなりやすい。また、男性ホルモンはストレスにより低下する。超高齢化ストレス社会において、この解決に男性ホルモン低下を予防するための食品等による男性ホルモンの強化が望まれている。 Testosterone, which accounts for 95% of male hormones, is secreted from the testes and has a powerful function of building bones and muscles as well as male gonad function, and even females make it in the ovaries. It also affects the brain and is involved in energy and cognitive function. Testosterone is known to decrease with aging, and a symptomatology called male menopause appears in which not only gonad function but also memory and motivation decline. Menopause tends to be too late as it progresses slowly. Androgens are reduced by stress. In a super-aging stress society, it is desired to strengthen male hormones with foods and the like to prevent the decrease of male hormones in order to solve this problem.

テストステロン生合成の主原料は「コレステロール」であり、その他ビタミン、亜鉛などの各種ミネラル、必須アミノ酸、アルギニンなどの血行促進成分など、様々な成分により複雑な過程を経て合成される。そのため、テストステロン生合成には、なかなか普段の食事では十分摂れないミネラル、ビタミンなどの「補酵素」と呼ばれる栄養素を意識して補給することが最も効果的である。 The main raw material for testosterone biosynthesis is "cholesterol", which is synthesized through a complicated process by various components such as vitamins, various minerals such as zinc, essential amino acids, and blood circulation promoting components such as arginine. Therefore, for testosterone biosynthesis, it is most effective to consciously supplement nutrients called "coenzymes" such as minerals and vitamins that cannot be easily taken in a normal diet.

特許文献1には、ビタミンKを有効成分として含有するテストステロン増加剤が記載されており、ビタミンK1は、青しそ、エゴマ、モロヘイヤ、パセリ、春菊等の他、トマトに含有されていることが記載されている。 Patent Document 1 describes a testosterone increasing agent containing vitamin K as an active ingredient, and describes that vitamin K1 is contained in tomatoes in addition to green perilla, egoma, moroheiya, parsley, and garland chrysanthemum. Has been done.

しかしながら、非特許文献1によると、食品100g当たりのビタミンKの含有量は、パセリが850μg、しそが690μg、モロヘイヤが640μg、春菊(ゆで)が460μgであるのに対して、トマトでは4μgであり、トマトを用いる場合には、ビタミンKの含有量が高くなるように精製しない限り、ビタミンKの効果は期待できない。 However, according to Non-Patent Document 1, the content of vitamin K per 100 g of food is 850 μg for parsley, 690 μg for shiso, 640 μg for moroheiya, and 460 μg for garland chrysanthemum (boiled), whereas it is 4 μg for tomato. When tomatoes are used, the effect of vitamin K cannot be expected unless they are purified so that the content of vitamin K is high.

また、特許文献2には、トマト果実の2−メチル−1,3−プロパンジオール抽出物が皮膚中の活性型TGFβ−1濃度を増加させ、繊維芽細胞の増殖の促進により、抗老化効果を奏することが記載されている。
特許文献3には、トマト果実由来の非水溶性成分及びアラニンを含有する飲食品が血中アルコール濃度低減効果を奏することが記載されている。
特許文献4には、トマト果実由来の水溶性成分を含有し、実質的にリコペン含有しないトマト由来の組成物が抗血栓剤として有用であることが記載されている。
Further, in Patent Document 2, 2-methyl-1,3-propanediol extract of tomato fruit increases the concentration of active TGFβ-1 in the skin and promotes the proliferation of fibroblasts, thereby exhibiting an anti-aging effect. It is described to play.
Patent Document 3 describes that foods and drinks containing a water-insoluble component derived from tomato fruit and alanine have an effect of reducing blood alcohol concentration.
Patent Document 4 describes that a tomato-derived composition containing a water-soluble component derived from tomato fruit and substantially free of lycopene is useful as an antithrombotic agent.

しかしながら、トマトの乾燥粉末、トマト果実由来の水溶性成分等とテストステロン増加作用の関係についてはこれまで報告されていない。 However, the relationship between the dry powder of tomato, the water-soluble component derived from tomato fruit, and the testosterone-increasing action has not been reported so far.

特許第5110478号公報(請求項1、段落0019)Japanese Patent No. 5110478 (Claim 1, paragraph 0019) 特許第5511284号公報(請求項1〜3、段落0001)Japanese Patent No. 5511284 (claims 1 to 3, paragraph 0001) 特許第5801515号公報(請求項1、8〜11)Japanese Patent No. 5801515 (Claims 1, 8-11) 特許第4975902号公報(請求項1〜3)Japanese Patent No. 4975902 (claims 1 to 3)

ビタミンKの多い食品と、食品のビタミンKの含有量一覧表、インターネット<URL:http://www.eiyoukeisan.com/calorie/nut_list/vitamin_k.html>Vitamin K-rich foods and vitamin K content list of foods, Internet <URL: http://www.eiyoukeisan.com/calorie/nut_list/vitamin_k.html>

本発明の課題は、安全性の高いテストステロン増加剤を提供することである。 An object of the present invention is to provide a highly safe testosterone increasing agent.

前記課題を解決すべく、本発明者らは、安全性が確立されているトマトから調製したトマトの乾燥粉末、抽出物又はそれらの処理物を摂取することにより、テストステロンの低下を抑制できることを見出し、本発明を完成するに至った。
すなわち、本発明の要旨は以下のとおりである。
(1)トマトの乾燥粉末、抽出物又はそれらの処理物を含有するテストステロン増加剤。
(2)トマト果実由来の水溶性成分を含有する前記(1)に記載のテストステロン増加剤。
(3)実質的にリコペンを含有しない前記(2)に記載のテストステロン増加剤。
(4)実質的にトマト果実由来の非水溶性成分を含有しない前記(2)に記載のテストステロン増加剤。
(5)トマト果実由来の水溶性成分を含有し、実質的にリコペンを含有しないテストステロン増加剤。
(6)実質的にトマト果実由来の非水溶性成分を含有しない前記(5)に記載のテストステロン増加剤。
(7)食品として用いる前記(1)〜(6)のいずれかに記載のテストステロン増加剤。
In order to solve the above problems, the present inventors have found that a decrease in testosterone can be suppressed by ingesting a dry powder, an extract or a processed product thereof of tomato prepared from tomatoes whose safety has been established. , The present invention has been completed.
That is, the gist of the present invention is as follows.
(1) A testosterone increasing agent containing a dry powder of tomato, an extract or a processed product thereof.
(2) The testosterone increasing agent according to (1) above, which contains a water-soluble component derived from tomato fruit.
(3) The testosterone increasing agent according to (2) above, which does not substantially contain lycopene.
(4) The testosterone increasing agent according to (2) above, which does not substantially contain a water-insoluble component derived from tomato fruit.
(5) A testosterone-increasing agent containing a water-soluble component derived from tomato fruit and substantially free of lycopene.
(6) The testosterone increasing agent according to (5) above, which does not substantially contain a water-insoluble component derived from tomato fruit.
(7) The testosterone increasing agent according to any one of (1) to (6) above, which is used as a food.

本発明によれば、安全性の高いテストステロン増加剤を提供することができる。 According to the present invention, it is possible to provide a highly safe testosterone increasing agent.

図1は精巣障害モデルにおける精巣初代培養細胞からのテストステロン分泌量を示す。FIG. 1 shows the amount of testosterone secreted from primary testis cultured cells in a testis disorder model. 図2は慢性ストレスモデルにおける精巣初代培養細胞からのテストステロン分泌量を示す。FIG. 2 shows the amount of testosterone secreted from primary testis cultured cells in a chronic stress model. 図3はPAO活性の測定結果を示す。FIG. 3 shows the measurement results of PAO activity. 図4は慢性ストレスモデルにおける精巣初代培養細胞からのテストステロン分泌量を示す。FIG. 4 shows the amount of testosterone secreted from primary testis cultured cells in a chronic stress model. 図5は慢性ストレスモデルにおける精巣のグルタチオンペルオキシダーゼ活性を示す。FIG. 5 shows testicular glutathione peroxidase activity in a chronic stress model. 図6は慢性ストレスモデルにおける精巣初代培養細胞からのテストステロン分泌量を示す。FIG. 6 shows the amount of testosterone secreted from primary testis cultured cells in a chronic stress model.

本発明において、トマト(Solanum lycopersicum)としては、通常、果実の乾燥粉末、抽出物又はその処理物が用いられる。原料として用いるトマト果実としては、PAO(potential anti oxidant)活性が高いものを用いることが好ましい。このようなトマトは、極少培地多頻度少量給液法により栽培することにより得ることができる。極少培地多頻度少量給液法における一株当たりの培地量は、通常1000ml未満、好ましくは200〜500mlである。 In the present invention, as tomato (Solanum lycopersicum), a dry powder of fruit, an extract or a processed product thereof is usually used. As the tomato fruit used as a raw material, it is preferable to use one having high PAO (potential anti-oxidant) activity. Such tomatoes can be obtained by cultivating them by a method of supplying a very small amount of medium frequently and in a small amount. The amount of medium per strain in the ultra-small medium frequent small amount feeding method is usually less than 1000 ml, preferably 200 to 500 ml.

トマト果実の乾燥粉末としては、例えば、トマト果実を丸ごとピューレ化後、必要に応じて、濾過して不溶物を除去した後、乾燥粉末化して得られる粉末、トマト果実を乾燥後、常法により粉砕して得られる粉末、抽出物の乾燥粉末が挙げられる。 Examples of the dry powder of tomato fruit include a powder obtained by pureing the whole tomato fruit, filtering it to remove insoluble matter, and then drying the tomato fruit, and then drying the tomato fruit by a conventional method. Examples include powder obtained by crushing and dry powder of an extract.

トマト抽出物を得るために用いる溶媒としては、水;アルコール類、例えばメタノール、エタノール、プロパノール、ブタノール;エステル類、例えば酢酸エチル等の酢酸エステル;エーテル類、例えばエチルエーテル、ジオキサン;ケトン類、例えばアセトン等が挙げられる。抽出物を一旦溶媒除去して乾燥物として用いる場合には、前述した任意の溶媒を単独で又は混合して用いることができる。一方、抽出物を溶媒に溶解した状態で用いる場合には、人体に対して有害な作用を示さない溶媒を用いる必要があり、この場合には、水、エタノール又はこれらの混合物を用いることが好ましい。抽出に際して、トマト果実は、そのまま用いることができ、また乾燥後に破砕又は粉砕して溶媒との接触を高めることもできる。 Solvents used to obtain tomato extracts include water; alcohols such as methanol, ethanol, propanol, butanol; esters such as acetate such as ethyl acetate; ethers such as ethyl ether, dioxane; ketones such as ketones. Acetone and the like can be mentioned. When the extract is once removed from the solvent and used as a dried product, any of the above-mentioned solvents can be used alone or in combination. On the other hand, when the extract is used in a state of being dissolved in a solvent, it is necessary to use a solvent that does not have a harmful effect on the human body, and in this case, it is preferable to use water, ethanol or a mixture thereof. .. At the time of extraction, the tomato fruit can be used as it is, or it can be crushed or crushed after drying to enhance the contact with the solvent.

トマト果実1kg当り溶媒2〜4Lで抽出する。抽出温度は、室温ないし溶媒の常圧下での沸点の範囲内であり、抽出時間は、抽出温度等により異なるが、好ましくは、室温の場合24〜30時間、溶媒の常圧下での沸点で行う場合0.5〜2時間である。 Extract with 2-4 L of solvent per kg of tomato fruit. The extraction temperature is within the range of room temperature or the boiling point of the solvent under normal pressure, and the extraction time varies depending on the extraction temperature and the like, but is preferably performed at room temperature for 24 to 30 hours at the boiling point of the solvent under normal pressure. The case is 0.5 to 2 hours.

このようにして得られた抽出液は、必要に応じて、布、ステンレスフィルター、濾紙、濾過滅菌用フィルター等で濾過して不溶物、不純物等を除去して用いてもよい。また、濾過後の抽出液に、スプレードライ処理、フリーズドライ処理、超臨界処理等の処理を施してもよい。 The extract thus obtained may be used by filtering it with a cloth, a stainless steel filter, a filter paper, a filter for filtration sterilization or the like to remove insoluble matter, impurities and the like, if necessary. Further, the extracted extract after filtration may be subjected to a treatment such as a spray-drying treatment, a freeze-drying treatment, or a supercritical treatment.

前記のようにして得られる乾燥粉末、抽出物又はその処理物は、そのまま本発明のテストステロン増加剤の有効成分として用いることができる。また、当該抽出物等をイオン交換クロマトグラフィー、ゲル濾過クロマトグラフィー、透析等の各種精製手段により処理し、更に活性を高めた処理物として用いてもよい。
また、トマトの乾燥粉末、抽出物又はそれらの処理物を含有する本発明のテストステロン増加剤は、リコペン等のトマト果実由来の非水溶性成分を含有してもよいが、製剤上の理由等の点から、リコペン等のトマト果実由来の非水溶性成分を除去して、当該非水溶性成分を実質的に含有しない組成物として用いてもよい。
ここで、リコペン等のトマト果実由来の非水溶性成分を「実質的に含有しない」とは、当該非水溶性成分による影響がない程度に夾雑物として含有する場合を除外するものではない。
リコペン等のトマト果実由来の非水溶性成分を除去する方法としては、特に制限はないが、例えば、トマトの乾燥粉末、抽出物又はそれらの処理物を含有する組成物を遠心分離して、固形分を沈殿、除去して上澄み液を採取すればよい。
The dry powder, extract or processed product thereof obtained as described above can be used as it is as an active ingredient of the testosterone increasing agent of the present invention. Further, the extract or the like may be treated by various purification means such as ion exchange chromatography, gel filtration chromatography, dialysis and the like to be used as a treated product having further enhanced activity.
Further, the testosterone increasing agent of the present invention containing a dry powder of tomato, an extract or a processed product thereof may contain a water-insoluble component derived from tomato fruit such as lycopene, but for reasons such as formulation. From the point of view, the water-insoluble component derived from tomato fruit such as lycopene may be removed and used as a composition substantially free of the water-insoluble component.
Here, "substantially free of water-insoluble components derived from tomato fruits such as lycopene" does not exclude the case where they are contained as impurities to the extent that the water-insoluble components do not affect them.
The method for removing the water-insoluble component derived from tomato fruit such as lycopene is not particularly limited, but for example, a composition containing a dry powder of tomato, an extract or a processed product thereof is centrifuged and solidified. The minutes may be precipitated and removed, and the supernatant may be collected.

本発明のテストステロン増加剤は、トマトの乾燥粉末、抽出物又はそれらの処理物、あるいはこれらの組成物からリコペン等のトマト果実由来の非水溶性成分を除去して得られる、当該非水溶性成分を実質的に含有しない組成物を公知の食品用担体又は医薬用担体と組合せて製剤化することができる。投与形態としては、特に制限はなく、必要に応じ適宜選択されるが、一般には錠剤、カプセル剤、顆粒剤、細粒剤、散剤、液剤、シロップ剤、懸濁剤、乳剤、エリキシル剤等の経口剤として使用される。また、本発明のテストステロン増加剤は、注射剤、点滴剤、坐剤、吸入剤、経皮吸収剤、経粘膜吸収剤、貼付剤、軟膏剤等の非経口剤として使用してもよい。また、本発明のテストステロン増加剤は、食品、チューインガム、飲料等に添加して、いわゆる特定保健用食品又は機能性表示食品(例えば、男性ホルモン増加用食品、ストレス改善用食品、疲労回復用食品、男性更年期障害予防用食品)等とすることもできる。 The testosterone increasing agent of the present invention is obtained by removing a water-insoluble component derived from tomato fruit such as lycopene from a dry powder of tomato, an extract or a processed product thereof, or a composition thereof. A composition substantially free of the above can be formulated in combination with a known food carrier or pharmaceutical carrier. The dosage form is not particularly limited and may be appropriately selected as needed, but generally includes tablets, capsules, granules, fine granules, powders, liquids, syrups, suspensions, emulsions, elixirs and the like. Used as an oral preparation. In addition, the testosterone increasing agent of the present invention may be used as a parenteral agent such as an injection, a drip, a suppository, an inhalant, a transdermal absorbent, a transmucosal absorbent, a patch, and an ointment. Further, the testosterone increasing agent of the present invention is added to foods, chewing gums, beverages, etc., so-called foods for specified health use or foods with functional claims (for example, foods for increasing male hormones, foods for improving stress, foods for recovery from fatigue, etc. It can also be used as a food for preventing male menopausal disorders).

本発明のテストステロン増加剤の投与量は、患者の年令、体重、疾患の程度、投与経路により異なるが、経口投与では、トマトの乾燥粉末及び抽出物等では、乾燥粉末として、通常1日15〜500mgであり、投与回数は、通常、経口投与では1日1〜3回である。 The dose of the testosterone-increasing agent of the present invention varies depending on the age, body weight, degree of disease, and route of administration of the patient. The dose is ~ 500 mg, and the number of administrations is usually 1 to 3 times a day for oral administration.

経口剤は、例えばデンプン、乳糖、白糖、マンニット、カルボキシメチルセルロース、コーンスターチ、無機塩類等の賦形剤を用いて常法に従って製造される。 Oral preparations are prepared according to conventional methods using excipients such as starch, lactose, sucrose, mannitol, carboxymethyl cellulose, cornstarch, and inorganic salts.

前記の製剤には、適宜前記賦形剤の他に、結合剤、崩壊剤、界面活性剤、滑沢剤、流動性促進剤、矯味剤、着色剤、香料等を使用することができる。 In the above-mentioned preparation, in addition to the above-mentioned excipient, a binder, a disintegrant, a surfactant, a lubricant, a fluidity accelerator, a flavoring agent, a coloring agent, a fragrance and the like can be appropriately used.

結合剤の具体例としては、結晶セルロース、結晶セルロース・カルメロースナトリウム、メチルセルロース、ヒドロキシプロピルセルロース、低置換度ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、ヒドロキシプロピルメチルセルロースフタレート、ヒドロキシプロピルメチルセルロースアセテートサクシネート、カルメロースナトリウム、エチルセルロース、カルボキシメチルエチルセルロース、ヒドロキシエチルセルロース、コムギデンプン、コメデンプン、トウモロコシデンプン、バレイショデンプン、デキストリン、アルファー化デンプン、部分アルファー化デンプン、ヒドロキシプロピルスターチ、プルラン、ポリビニルピロリドン、アミノアルキルメタクリレートコポリマーE、アミノアルキルメタクリレートコポリマーRS、メタクリル酸コポリマーL、メタクリル酸コポリマー、ポリビニルアセタールジエチルアミノアセテート、ポリビニルアルコール、アラビアゴム、アラビアゴム末、寒天、ゼラチン、白色セラック、トラガント、精製白糖、マクロゴールが挙げられる。 Specific examples of the binder include crystalline cellulose, crystalline cellulose carmellose sodium, methyl cellulose, hydroxypropyl cellulose, low-substituted hydroxypropyl cellulose, hydroxypropyl methyl cellulose, hydroxypropyl methyl cellulose phthalate, hydroxypropyl methyl cellulose acetate succinate, and carmellose sodium. , Ethyl cellulose, carboxymethyl ethyl cellulose, hydroxyethyl cellulose, wheat starch, rice starch, corn starch, potato starch, dextrin, pregelatinized starch, partially pregelatinized starch, hydroxypropyl starch, purulan, polyvinylpyrrolidone, aminoalkyl methacrylate copolymer E, aminoalkyl Examples thereof include methacrylate copolymer RS, methacrylic acid copolymer L, methacrylic acid copolymer, polyvinyl acetal diethylaminoacetate, polyvinyl alcohol, gum arabic, rubber arabic powder, agar, gelatin, white cellac, tragant, purified sucrose, and macrogol.

崩壊剤の具体例としては、結晶セルロース、メチルセルロース、低置換度ヒドロキシプロピルセルロース、カルメロース、カルメロースカルシウム、カルメロースナトリウム、クロスカルメロースナトリウム、コムギデンプン、コメデンプン、トウモロコシデンプン、バレイショデンプン、部分アルファー化デンプン、ヒドロキシプロピルスターチ、カルボキシメチルスターチナトリウム、トラガントが挙げられる。 Specific examples of the disintegrant include crystalline cellulose, methyl cellulose, low-substituted hydroxypropyl cellulose, carmellose, carmellose calcium, carmellose sodium, croscarmellose sodium, wheat starch, rice starch, corn starch, potato starch, and partial pregelatinization. Examples include starch, hydroxypropyl starch, sodium carboxymethyl starch and tragant.

界面活性剤の具体例としては、大豆レシチン、ショ糖脂肪酸エステル、ステアリン酸ポリオキシル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンポリオキシプロピレングリコール、セスキオレイン酸ソルビタン、トリオレイン酸ソルビタン、モノステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、ポリソルベート、モノステアリン酸グリセリン、ラウリル硫酸ナトリウム、ラウロマクロゴールが挙げられる。 Specific examples of surfactants include soybean lecithin, sucrose fatty acid ester, polyoxyl stearate, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol, sorbitan sesquioleate, sorbitan trioleate, and sorbitan monostearate. , Polysorbate monopalmitate, sorbitan monolaurate, polysorbate, glycerin monostearate, sodium lauryl sulfate, lauromacrogol.

滑沢剤の具体例としては、コムギデンプン、コメデンプン、トウモロコシデンプン、ステアリン酸、ステアリン酸カルシウム、ステアリン酸マグネシウム、含水二酸化ケイ素、軽質無水ケイ酸、合成ケイ酸アルミニウム、乾燥水酸化アルミニウムゲル、タルク、メタケイ酸アルミン酸マグネシウム、リン酸水素カルシウム、無水リン酸水素カルシウム、ショ糖脂肪酸エステル、ロウ類、水素添加植物油、ポリエチレングリコールが挙げられる。 Specific examples of lubricants include wheat starch, rice starch, corn starch, stearic acid, calcium stearate, magnesium stearate, hydrous silicon dioxide, light anhydrous silicic acid, synthetic aluminum silicate, dry aluminum hydroxide gel, talc, etc. Examples thereof include magnesium aluminometasilicate, calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, sucrose fatty acid ester, braces, hydrogenated vegetable oil, and polyethylene glycol.

流動性促進剤の具体例としては、含水二酸化ケイ素、軽質無水ケイ酸、乾燥水酸化アルミニウムゲル、合成ケイ酸アルミニウム、ケイ酸マグネシウムが挙げられる。 Specific examples of the fluidity accelerator include hydrous silicon dioxide, light anhydrous silicic acid, dry aluminum hydroxide gel, synthetic aluminum silicate, and magnesium silicate.

また、本発明のテストステロン増加剤は、液剤、シロップ剤、懸濁剤、乳剤、エリキシル剤として投与する場合には、矯味矯臭剤、着色剤を含有してもよい。
本発明のテストステロン増加剤の製造原料であるトマトは、食用に供されており、安全性は確立されている。
In addition, the testosterone increasing agent of the present invention may contain a flavoring agent and a coloring agent when administered as a liquid agent, a syrup agent, a suspending agent, an emulsion, or an elixir agent.
The tomato, which is a raw material for producing the testosterone increasing agent of the present invention, is edible and its safety has been established.

以下、本発明を実施例により説明するが、本発明は、以下の実施例に限定されるものではない。
(製造例1)トマト粉末の調製
トマト(Solanum lycopersicum)果実を丸ごとピューレ化した後、乾燥粉末化してトマト粉末を得た。
ここで用いたトマト果実は、極少培地多頻度少量給液法による栽培(一株当たりの培地量:300ml、培地の種類:ココナツの実の繊維や粉末を乾かして粉砕したヤシガラ培地)で得られたものであり、株式会社うまヘルシーから入手した。
Hereinafter, the present invention will be described with reference to Examples, but the present invention is not limited to the following Examples.
(Production Example 1) Preparation of tomato powder The whole tomato (Solanum lycopersicum) fruit was pureed and then dried and powdered to obtain tomato powder.
The tomato fruits used here are obtained by cultivating with a very small amount of medium and a small amount of liquid feeding method (medium amount per plant: 300 ml, medium type: coconut fruit fibers and powder dried and crushed coconut husk medium). It was obtained from Uma Healthy Co., Ltd.

(実施例1)トマト粉末によるテストステロン分泌能の増加効果
加齢やストレスにより精巣(睾丸)からの男性ホルモン(テストステロン)分泌能が低下することが知られている。そこで、以下の試験では、精巣障害モデル及びストレスモデルのマウスによる2つのモデル実験おいて、トマト粉末によるテストステロン分泌能の増加効果を検討した。
(Example 1) Effect of increasing testosterone secretion by tomato powder It is known that the secretion of male hormone (testosterone) from the testis (testis) decreases due to aging and stress. Therefore, in the following tests, the effect of tomato powder on increasing testosterone secretion was examined in two model experiments using a testis disorder model and a stress model mouse.

(試験方法1)精巣障害モデル
マウス(ddY系、オス、7週齢)を3群に分け、第1群は、通常食(MF,オリエンタル酵母)を摂取させ、何も処置しない群、第2群は、通常食を摂取させ、シスプラチン(2.5mg/kg)を腹腔に投与した群、第3群は、10%トマト粉末(製造例1で得られたトマト粉末)を含む試験食を摂取させ、シスプラチン(2.5mg/kg)を腹腔に投与した群とした。各群はn=3とした。飼育開始1週間後、精巣を取り出し、初代培養法にて精巣細胞を培養した。一夜、培養後、刺激剤としてヒト絨毛性ゴナドトロピン(hCG)(1U)を添加して、精巣からのテストステロン分泌量を、EIA法にて定量測定した。
(Test method 1) Testicular disorder model mice (ddY system, male, 7 weeks old) were divided into 3 groups, the 1st group was ingested with a normal diet (MF, oriental yeast), and no treatment was performed, the 2nd group. The group ingested a normal diet and cisplatin (2.5 mg / kg) was intraperitoneally administered, and the third group ingested a test diet containing 10% tomato powder (tomato powder obtained in Production Example 1). The group was divided into a group in which cisplatin (2.5 mg / kg) was intraperitoneally administered. Each group was set to n = 3. One week after the start of breeding, the testis was taken out and the testis cells were cultured by the primary culture method. After culturing overnight, human chorionic gonadotropin (hCG) (1U) was added as a stimulant, and the amount of testosterone secreted from the testis was quantitatively measured by the EIA method.

(試験方法2)ストレスモデル
マウス(ddY系、オス、7週齢)を3群に分け、第1群は、通常食(MF,オリエンタル酵母)を摂取させ、何も処置しない群、第2群は、通常食を摂取させた群、第3群は、10%トマト粉末(製造例1で得られたトマト粉末)を含む試験食を摂取させた。第2群と第3群は、飼育5〜7日目に、拘束ストレス処理を行った。拘束は、通気孔を多数開けたプラスチックチューブ(50ml)に約12時間入れた。各群はn=3とした。飼育開始1週間後、精巣を取り出し、初代培養法にて精巣細胞を培養した。一夜、培養後、刺激剤としてヒト絨毛性ゴナドトロピン(hCG)(1U)を添加して、精巣からのテストステロン分泌量を免疫測定(EIA)法にて定量測定した。
(Test method 2) Stress model mice (ddY system, male, 7 weeks old) were divided into 3 groups, and the 1st group was ingested with a normal diet (MF, oriental yeast) and no treatment was performed, the 2nd group. Was fed a normal diet, and the third group was fed a test diet containing 10% tomato powder (tomato powder obtained in Production Example 1). The second and third groups were subjected to restraint stress treatment on the 5th to 7th days of breeding. Restraint was placed in a plastic tube (50 ml) with many vents for about 12 hours. Each group was set to n = 3. One week after the start of breeding, the testis was taken out and the testis cells were cultured by the primary culture method. After culturing overnight, human chorionic gonadotropin (hCG) (1U) was added as a stimulant, and the amount of testosterone secreted from the testis was quantitatively measured by the immunoassay (EIA) method.

(試験結果)
精巣障害モデルの結果を図1に示す。精巣障害を起こさせたところ、精巣からのテストステロン分泌量は、シスプラチンを投与し、通常食を摂取させた群では、無処置群に比して、有意に低下し、シスプラチンによる精巣障害がおこりテストステロン分泌量の低下がみられた。一方、シスプラチンを投与し、トマト粉末を摂取させた群では、シスプラチンを投与し、通常食を摂取させた群に比し、有意に増加し、シスプラチン非投与の無処置群とほぼ同レベルまで、精巣障害を抑制できることが示された。
(Test results)
The results of the testicular disorder model are shown in FIG. When testicular disorders were caused, the amount of testosterone secreted from the testes was significantly lower in the group to which cisplatin was administered and fed with a normal diet than in the untreated group, and cisplatin-induced testosterone disorders occurred and testosterone. There was a decrease in secretion. On the other hand, in the group to which cisplatin was administered and tomato powder was ingested, the increase was significantly higher than that in the group to which cisplatin was ingested and the normal diet was ingested, and to almost the same level as the untreated group in which cisplatin was not administered. It was shown that testicular damage can be suppressed.

慢性ストレスモデルの結果を図2に示す。精巣からのテストステロン分泌量は、通常食を摂取後、拘束ストレス処理を行った群(慢性ストレス群、第2群)では、慢性ストレスを与えない無処置群(第1群)に比し、テストステロン分泌量が有意に低下し、精巣機能低下が観察された。一方、拘束ストレス負荷とともにトマト粉末を摂取させておいた群(トマト粉末摂取群)では、通常食を摂取後、拘束ストレス処理を行った群(慢性ストレス群、第2群)に比し、テストステロン分泌量が有意に増加し、ストレスによる精巣機能低下を抑制できることが示唆された。 The results of the chronic stress model are shown in FIG. The amount of testosterone secreted from the testes was higher in the group that received restraint stress treatment after ingesting a normal diet (chronic stress group, group 2) than in the untreated group that did not give chronic stress (group 1). The amount of secretion was significantly reduced, and testicular dysfunction was observed. On the other hand, in the group in which tomato powder was ingested together with the restraint stress load (tomato powder intake group), testosterone was compared with the group in which restraint stress treatment was performed after ingesting a normal diet (chronic stress group, second group). It was suggested that the amount of secretion was significantly increased and that the decrease in testosterone function due to stress could be suppressed.

(効果)
加齢により男性ホルモン量は徐々に低下し、性腺機能のみならず筋力低下、活力低下等の男性更年期障害といわれる様々な症状があらわれる。トマト粉末の摂取により、これら更年期症状の防止が期待できる。また、慢性ストレスによる男性ホルモン量低下に対しても同様に効果があることから、ストレス軽減効果も認められる。
(effect)
With aging, the amount of androgen gradually decreases, and various symptoms called male menopause such as hypogonadism, muscle weakness, and vitality appear. Ingestion of tomato powder can be expected to prevent these menopausal symptoms. In addition, since it has the same effect on the decrease in the amount of male hormone due to chronic stress, a stress-reducing effect is also recognized.

超高齢・ストレス社会において、寝たきり防止のための方策には、まずサルコペニアといわれる筋力低下を防止することが必要とされ、男性ホルモン低下の防止が重要と考えられている。また、女性においても副腎アンドロゲンといわれるホルモンが同様の作用を担うとされる。更に、意欲・活力等の精神的活動に対しても男性ホルモンが影響することから、トマト粉末摂取がこれらQOLを維持する効果が期待される。 In a super-aged and stressed society, it is first necessary to prevent muscle weakness called sarcopenia as a measure to prevent bedridden, and it is considered important to prevent androgen decrease. In women, a hormone called adrenal androgen is said to have a similar effect. Furthermore, since male hormones also affect mental activities such as motivation and vitality, ingestion of tomato powder is expected to have the effect of maintaining these QOLs.

(参考例1)PAO活性に対するトマトの栽培法の影響
PAO(potential anti oxidant)活性に対するトマトの栽培法の影響を検討するため、以下の2つの条件で栽培を行った。
試験区:極少培地多頻度少量給液法による栽培(一株当たりの培地量:300ml)
対照区:バック栽培(一株当たりの培地量:4000ml以上)
試験区は、根域を極端に制限することで根に自然にストレスが掛かり、トマト栽培の熟練者でなくても比較的容易にトマトの品質が上がるとされている栽培である。
試験区で栽培されたトマトのPAO活性が慣行栽培(対照区栽培)によってできたトマトに比べどれほど上がるかを分析した。
(Reference Example 1) Effect of tomato cultivation method on PAO activity In order to examine the effect of tomato cultivation method on PAO (potential antioxidant) activity, cultivation was carried out under the following two conditions.
Test group: Cultivation by the ultra-low medium frequency small amount liquid supply method (medium amount per strain: 300 ml)
Control group: Back cultivation (medium amount per strain: 4000 ml or more)
The test plot is a cultivation in which the roots are naturally stressed by extremely limiting the root area, and it is said that the quality of tomatoes can be improved relatively easily even if the person is not an expert in tomato cultivation.
It was analyzed how much the PAO activity of tomatoes cultivated in the test plot was higher than that of tomatoes cultivated by conventional cultivation (control plot cultivation).

(1)試料の調製
トマト(試験区、対照区、それぞれ12個ずつ)を4つ切りにし、その4分の1を秤量後、ポリ試験管(50ml)に入れ、ポリトロンホモジナイザーで均一化させ、遠心分離機(5,000rpm,10分)にて、固形分を沈殿させた。上澄み液を採取し、−20℃にて保存した。測定前に、その一部をとり、0.45μmのフィルターにて濾過し、僅かに残る不溶物を除去し、これをPAO活性測定用試料とした。
(1) Preparation of sample Cut tomatoes (12 each in a test group and a control group) into 4 pieces, weigh a quarter of the tomatoes, put them in a poly test tube (50 ml), and homogenize them with a polytron homogenizer. The solid content was precipitated by a centrifuge (5,000 rpm, 10 minutes). The supernatant was collected and stored at −20 ° C. Before the measurement, a part thereof was taken and filtered through a 0.45 μm filter to remove a slight amount of insoluble matter, which was used as a sample for measuring PAO activity.

(2)PAO活性の測定
PAO抗酸化能測定キット(日研ザイル(株)日本老化制御研究所)により、使用説明書に記載された方法によりPAO活性の測定を行った。
標準物質2mM尿酸を適宜希釈し、希釈系列を作製した。試験管6本に濃度の異なる標準物質10μl、及び水390μlを添加し希釈した。また別途、試験管に前記トマト試料(果汁)10μl及び水390μlをとり希釈した。マイクロプレートに、これら希釈標準物質及び希釈試料を添加し、各ウェルに銅試薬50μlを添加撹拌し、3分反応させた。反応停止薬を各ウェルに添加撹拌し、マイクロプレートリーダーで490nmにおける吸光度を測定した。標準物質の検量線に基づき、試料の尿酸相当濃度を求め、これに銅還元力係数2189を乗し、これをPAO活性値として表した。
(2) Measurement of PAO activity PAO activity was measured by the method described in the instruction manual using the PAO antioxidant capacity measurement kit (Nikken Zile Co., Ltd. Japan Aging Control Laboratory).
The standard substance 2 mM uric acid was appropriately diluted to prepare a dilution series. To 6 test tubes, 10 μl of a standard substance having a different concentration and 390 μl of water were added and diluted. Separately, 10 μl of the tomato sample (fruit juice) and 390 μl of water were taken in a test tube and diluted. These diluted standard substances and diluted samples were added to the microplate, 50 μl of copper reagent was added to each well, and the mixture was stirred and reacted for 3 minutes. The reaction terminator was added to each well and stirred, and the absorbance at 490 nm was measured with a microplate reader. Based on the calibration curve of the standard substance, the uric acid equivalent concentration of the sample was determined, and the copper reducing power coefficient 2189 was multiplied by this, and this was expressed as the PAO activity value.

結果を図3に示す。
PAO抗酸化活性は、試験区と対照区で有意の差がみられた。試料(果汁)は測定の都合上、濾過が必要であったため、ほぼ無色かつ水溶性であり、リコペン、カロテン、ビタミンK等の脂溶性物質のPAO抗酸化活性に対する寄与は少ないと推測される。水溶性の抗酸化物質によるものと考えられる。
The results are shown in FIG.
The PAO antioxidant activity was significantly different between the test group and the control group. Since the sample (fruit juice) needed to be filtered for the convenience of measurement, it was almost colorless and water-soluble, and it is presumed that the contribution of fat-soluble substances such as lycopene, carotene, and vitamin K to the PAO antioxidant activity was small. Probably due to water-soluble antioxidants.

PAO抗酸化活性をトマト平均1個重量あたりに換算したところ、試験区と対照区で有意の差がみられた。試験区でトマトの重量が減少した分を水分と仮定して、平均重量をPAO活性に乗じたところ、この分を考慮してもPAO活性は高かった。
対照区のPAO活性の最大値が2.16μmol/gであるのに対し、試験区のPAO活性の最大値は3.07μmol/gであった。
したがって、PAO活性が2.3〜3.5μmol/gのトマトを用いるのが好ましく、2.5〜3.5μmol/gのトマトを用いるのが更に好ましい。
When the PAO antioxidant activity was converted to the average weight of one tomato, a significant difference was observed between the test group and the control group. Assuming that the amount of decrease in tomato weight in the test plot was water, the average weight was multiplied by the PAO activity, and the PAO activity was high even when this amount was taken into consideration.
The maximum PAO activity of the control group was 2.16 μmol / g, whereas the maximum PAO activity of the test group was 3.07 μmol / g.
Therefore, it is preferable to use tomatoes having a PAO activity of 2.3 to 3.5 μmol / g, and more preferably tomatoes having a PAO activity of 2.5 to 3.5 μmol / g.

(実施例2)トマトの男性ホルモン分泌増加効果
(試験方法1)ストレスモデル
マウス(ddY系、オス、7週齢)を3群に分け、第1群は、無処置群とし、第2群と第3群は、飼育5〜7日目に、拘束ストレス処理を行った。拘束は、通気孔を多数開けたプラスチックチューブ(50ml)に約12時間入れた。第3群は、トマト果汁を飲水の代わりに摂取させた。トマト果汁は、市販ミキサーにてトマトを粉砕した後、遠心分離し、果肉等の不溶物を除去した透明な黄色の果汁とした。なお、これにはリコペンが殆ど含まれていない。いずれの群も、通常食(MF,オリエンタル酵母)を摂取させた。各群はn=4とした。1週間後、精巣を取り出し、初代培養法にて精巣細胞を調製した。一夜、培養後、細胞を洗浄後、3時間培養して培地を採取し、培地中のテストステロン分泌量を免疫測定(EIA)法にて定量測定した。また、精巣の一部をリン酸緩衝液にて抽出し、Flohe とGunzlerらの方法(Flohe,L., Gunzler,W.A., Schock, H.H., Glutathione peroxidase:a selenoenzyme.FEBS Lett., 32:132-134 (1973))により、グルタチオンペルオキシダーゼ活性(GPx)を測定した。
(Example 2) Effect of increasing androgen secretion of tomatoes (test method 1) Stress model mice (ddY system, male, 7 weeks old) were divided into 3 groups, and the first group was an untreated group and the second group. The third group was subjected to restraint stress treatment on the 5th to 7th days of breeding. Restraint was placed in a plastic tube (50 ml) with many vents for about 12 hours. The third group ingested tomato juice instead of drinking water. The tomato juice was obtained by crushing tomatoes with a commercially available mixer and then centrifuging to obtain a transparent yellow juice from which insoluble matter such as pulp was removed. It should be noted that this contains almost no lycopene. Both groups were fed a normal diet (MF, oriental yeast). Each group was set to n = 4. After 1 week, the testes were removed and testis cells were prepared by the primary culture method. After culturing overnight, the cells were washed, and the medium was collected by culturing for 3 hours, and the amount of testosterone secreted in the medium was quantitatively measured by an immunoassay (EIA) method. In addition, a part of the testis was extracted with phosphate buffer, and the method of Flohe and Gunzler et al. (Flohe, L., Gunzler, WA, Schock, HH, Glutathione peroxidase: a selenoenzyme.FEBS Lett., 32: 132- Glutathione peroxidase activity (GPx) was measured by 134 (1973)).

(試験方法2)ストレスモデル
マウス(ddY系、オス、7週齢)を3群に分け、第1群は、無処置群とし、第2群と第3群は、飼育5〜7日目に、拘束ストレス処理を行った。拘束は、通気孔を多数開けたプラスチックチューブ(50ml)に約12時間入れた。第3群は、飲水として1%ビタミンC水溶液を摂取させた。いずれの群も、通常食(MF, オリエンタル酵母)を摂取させた。各群はn=4とした。1週間後、精巣を取り出し、初代培養法にて精巣細胞を調製した。一夜、培養後、細胞を洗浄後、3時間培養して培地を採取し、培地中のテストステロン分泌量を免疫測定(EIA)法にて定量測定した。
(Test method 2) Stress model mice (ddY system, male, 7 weeks old) were divided into 3 groups, the 1st group was an untreated group, and the 2nd and 3rd groups were on the 5th to 7th day of breeding. , Restraint stress treatment was performed. Restraint was placed in a plastic tube (50 ml) with many vents for about 12 hours. The third group was fed with a 1% aqueous vitamin C solution as drinking water. Both groups were fed a normal diet (MF, Oriental yeast). Each group was set to n = 4. After 1 week, the testes were removed and testis cells were prepared by the primary culture method. After culturing overnight, the cells were washed, and the medium was collected by culturing for 3 hours, and the amount of testosterone secreted in the medium was quantitatively measured by an immunoassay (EIA) method.

(試験結果)
トマト果汁摂取の効果をストレスモデルで調べたところ、図4に示すように、ストレス負荷により精巣細胞からのテストステロン分泌量は、無処置群に比して低下したが、その間、トマト果汁を摂取させた群ではテストステロン分泌量が有意に増加し、ストレスによる精巣機能低下を抑制していることが示唆された。精巣のグルタチオンペルオキシダーゼ活性を調べたところ、果汁摂取群では慢性ストレス群より、有意の増加がみられた(図5)。
(Test results)
When the effect of ingestion of tomato juice was examined by a stress model, as shown in FIG. 4, the amount of testosterone secreted from testis cells decreased due to stress load as compared with the untreated group, but during that period, tomato juice was ingested. In the group, testosterone secretion was significantly increased, suggesting that stress-induced testicular dysfunction was suppressed. When the glutathione peroxidase activity of the testis was examined, a significant increase was observed in the fruit juice intake group as compared with the chronic stress group (Fig. 5).

また、ビタミンC摂取の効果を同様のストレスモデルで調べたところ、図6に示すように、ストレス負荷により精巣細胞からのテストステロン分泌量は、無処置群に比して低下したが、ビタミンCを摂取させた群ではテストステロン分泌量が僅かに増加した。 In addition, when the effect of vitamin C intake was investigated using a similar stress model, as shown in FIG. 6, the amount of testosterone secreted from the testosterone cells decreased due to stress loading as compared with the untreated group, but vitamin C was added. Testosterone secretion increased slightly in the ingested group.

(考察)
実施例1のリコペンを含むトマト粉末摂取によるテストステロン分泌低下抑制効果に加え、本実施例では、リコペンをほとんど含まないトマト果汁について、ストレスモデルにおいて、同様のテストステロン分泌低下抑制(増加)効果が認められた。そのうち、果汁に含まれるビタミンCを摂取させた同様の試験で、僅かに効果がみられたことから、トマト果汁のテストステロン増加作用はビタミンCが一部、寄与していると考えられるが、ビタミンC以外の水溶性成分の寄与も示唆された。本実施例の条件下では、抗酸化活性をもつビタミンCでは有意の増加を認めなかったが、精巣の抗酸化活性のうちグルタチオンペルオキシダーゼ活性が、果汁摂取により有意に増加したことから、果汁に含まれる抗酸化活性をもつ水溶性成分がテストステロン分泌に影響したことが示唆された。
(Discussion)
In addition to the effect of suppressing the decrease in testosterone secretion by ingesting tomato powder containing lycopene in Example 1, in this example, the same effect of suppressing (increasing) the decrease in testosterone secretion was observed in the stress model for tomato juice containing almost no lycopene. rice field. Among them, a similar test in which vitamin C contained in fruit juice was ingested showed a slight effect. Therefore, it is considered that vitamin C partially contributes to the testosterone-increasing effect of tomato juice. The contribution of water-soluble components other than C was also suggested. Under the conditions of this example, no significant increase was observed in vitamin C having antioxidant activity, but glutathione peroxidase activity among the antioxidant activity of the testis was significantly increased by ingestion of fruit juice, and thus it was contained in fruit juice. It was suggested that the water-soluble component with antioxidant activity affected testosterone secretion.

Claims (3)

トマト果実由来の水溶性成分を含有し、実質的にトマト果実由来の非水溶性成分を含有しないテストステロン増加剤。 A testosterone-increasing agent containing a water-soluble component derived from tomato fruit and substantially free of a water-insoluble component derived from tomato fruit. ストレスによりテストステロン分泌能が低下した対象に適用される請求項記載のテストステロン増加剤。 Testosterone enhancer according to claim 1, wherein the testosterone secretion is applied to the target was lowered by stress. 食品として用いる請求項1又は2記載のテストステロン増加剤。 The testosterone increasing agent according to claim 1 or 2, which is used as a food product.
JP2016111367A 2015-11-30 2016-06-02 Testosterone increaser Active JP6915774B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015234230 2015-11-30
JP2015234230 2015-11-30

Publications (2)

Publication Number Publication Date
JP2017105746A JP2017105746A (en) 2017-06-15
JP6915774B2 true JP6915774B2 (en) 2021-08-04

Family

ID=59060428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016111367A Active JP6915774B2 (en) 2015-11-30 2016-06-02 Testosterone increaser

Country Status (1)

Country Link
JP (1) JP6915774B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020080857A (en) * 2018-11-14 2020-06-04 株式会社テクノスルガ・ラボ Composition for promoting male hormone secretion
KR102371575B1 (en) * 2019-12-13 2022-03-08 주식회사 봄헬스케어 Food Composition for Neutered Companion Animal
JP7361076B2 (en) * 2020-08-13 2023-10-13 佳 川戸 testosterone booster

Also Published As

Publication number Publication date
JP2017105746A (en) 2017-06-15

Similar Documents

Publication Publication Date Title
KR20180103836A (en) Special nutritional or therapeutic formulations containing a mixture of grapes and blueberries
JP6915774B2 (en) Testosterone increaser
JP2005154432A (en) Treated material of acerola containing polyphenol and/or vitamin c
JP2013151451A (en) Antioxidation/antiallergic agent containing extract of impatiens
JP2005185188A (en) Composition containing treated product of acerola and l-carnitine
KR20110068958A (en) Pharmaceutical composition for improving obesity which comprises extract of lithospermum erythrorhizon as an active component
US20070003685A1 (en) Prostacyclin production-increasing agent and blood flow enhancer
Garrido et al. Characterization and trials of a jerte valley cherry product as a natural antioxidant-enriched supplement.
JP2012121840A (en) Blood triglyceride level rise inhibitor
KR101076535B1 (en) Food composition for relieving hangover which comprises extract of lithospermum erythrorhizon as an active component
KR101092197B1 (en) Food composition for improving fatty liver which comprises extract of tomato plant as an active component
KR101076185B1 (en) Pharmaceutical composition for improving fatty liver which comprises extract of tomato plant as an active component
KR101134251B1 (en) Food composition for improving obesity which comprises extract of torilis japonica as an active component
JP2005220100A (en) Anti-ageing agent, platelet aggregation inhibitor, antioxidant, anti-allergic agent, skin cosmetic, and food and drink
JP2015025008A (en) Anti-glycation composition
JP2011074062A (en) Anti-i type allergic agent
JP6320715B2 (en) Alcoholic fatty liver preventive and therapeutic agent
JP5279163B2 (en) Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent and food and drink
KR101076583B1 (en) Food composition for improving fatty liver which comprises extract of lithospermum erythrorhizon as an active component
WO2021106857A1 (en) Composition for preventing or relieving uresiesthesia stress, and composition for improving sleep
JP2009227622A (en) Therapeutic agent
JP4714438B2 (en) Anti-fatigue agent and food and drink containing the same
JP2007006839A (en) Frozen dessert containing royal jelly, pine bark extracted product and nucleic acid
JP2005104841A (en) Active oxygen scavenger and method for producing the same
KR20220079175A (en) Anti-inflammatory composition containing wheat germ extract

Legal Events

Date Code Title Description
AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20160627

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160627

A80 Written request to apply exceptions to lack of novelty of invention

Free format text: JAPANESE INTERMEDIATE CODE: A80

Effective date: 20160627

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190527

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200424

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200601

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200716

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201207

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210628

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210705

R150 Certificate of patent or registration of utility model

Ref document number: 6915774

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150